BioCentury This WeekWUSA9
About The Show Meet The Team Program Archive Become a Sponsor
      HOME     ABOUT BIOCENTURY     WHY BCTV?     PRESS RELEASES    FREE CONTENT    LINK TO BCTV    CONTACT US   
Advertisement
Advertisement

Free Content

Use our marquee links to make BioCentury This Week part of your home page! Our player style marquee links below make it very easy to do.

Your Webmaster can follow these easy steps:

  1. Select the program from the list below to which you want to link.
  2. Copy the html code in the box for that segment.
  3. Paste the copied html code into your home page.

If you want to link to multiple segments, select the first of your choices as the marquee link. The segments that follow will play automatically after your selection.

Questions: jfitzgerald@biocentury.com

That's it! You now have a marquee link like the one above.

NOTICE:
BioCentury Publications, Inc., and WUSA-TV own the copyright to the program content on "BioCentury This Week," and except for limited use of these links to the BioCenturytv.com website, BioCentury and WUSA prohibit hosting of BioCentury This Week program content by unauthorized third parties or posting of BioCentury This Week content to any unauthorized third party websites such as YouTube. Other BioCenturytv.com content and all trademarks are the property of BioCentury or WUSA-TV or other third parties.

Questions on authorized use may be directed to jfitzgerald@biocentury.com

 
BioCentury 09.14.14 - [1] Current Challenges
BioCentury 09.14.14 - [1] Current Challenges
After 38 years since the Ebola virus was identified, vaccine trials started last week. But will it be available in time to affect the current outbreak? Guests: NIAID Director Dr. Anthony Fauci, BARDA's Dr. Robin Robinson and GSK's Donna Atenpohl.
COPY THIS CODE:
 
 
BioCentury 09.14.14 - [2] BARDA's Role
BioCentury 09.14.14 - [2] BARDA's Role
Dr. Robinson on vaccines and therapeutics in early stage development: "The funding certainly as we go forward for the response is going to have to be accelerated to have more vaccines and more therapeutics available on the ground as we go into 2015."
COPY THIS CODE:
 
 
BioCentury 09.14.14 - [3] On The Horizon
BioCentury 09.14.14 - [3] On The Horizon
GlaxoSmithKline's Donna Altenpohl shares proposals for improving the way medicines are created: "I think there are a lot of opportunities to really create policies that make things more predictable when you do have these public health threats."
COPY THIS CODE:
 
 
BioCentury 09.14.14 - [4] Pieces of the Puzzle
BioCentury 09.14.14 - [4] Pieces of the Puzzle
Altenpohl on FDA's emergency use authority: "I think what would be helpful is if we had more clarity around exactly the criteria for when the emergency use authorization is applied".
COPY THIS CODE:
 
User Agreement | Terms of Use | Privacy Policy | Your California Privacy Rights | Use of Images

Advertisement